Oldham R
Cancer Metastasis Rev. 1983; 2(4):323-36.
PMID: 6375859
DOI: 10.1007/BF00048565.
Cochran A, Mackie R, Thomas C, Grant R, Spilg W
Br J Cancer Suppl. 1973; 1:77-82.
PMID: 4804293
PMC: 2149076.
Della Porta G, Canevari S, Fossati G
Br J Cancer Suppl. 1973; 1:103-7.
PMID: 4804274
PMC: 2149079.
Romsdahl M, Cox I
Yale J Biol Med. 1973; 46(5):693-701.
PMID: 4205125
PMC: 2592017.
Fritz J, Grond K, Tilz G
Arch Dermatol Res (1975). 1976; 255(2):203-9.
PMID: 1275554
DOI: 10.1007/BF00558528.
Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
KOURILSKY F, Picard F, BANZET P, Puissant A
Clin Exp Immunol. 1975; 21(3):430-41.
PMID: 1204255
PMC: 1538312.
[Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].
LISCHKA G
Arch Dermatol Res (1975). 1975; 253(2):105-12.
PMID: 1190833
DOI: 10.1007/BF00582062.
The influence of tumour burden and therapy on cellular cytotoxicity responses in patients with ocular and skin melanoma.
UNSGAARD B, OToole C
Br J Cancer. 1975; 31(3):301-16.
PMID: 1156516
PMC: 2009427.
DOI: 10.1038/bjc.1975.65.
Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
Marti J, Thomson D
Br J Cancer. 1976; 34(2):116-33.
PMID: 962991
PMC: 2025156.
DOI: 10.1038/bjc.1976.134.
Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.
Weber W, MISSMAHL H, Mazloumi B
Klin Wochenschr. 1978; 56(18):905-9.
PMID: 713420
DOI: 10.1007/BF01489216.
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.
Thatcher N, Palmer M, Gasiunas N, Crowther D
Br J Cancer. 1977; 36(6):751-62.
PMID: 597473
PMC: 2025560.
DOI: 10.1038/bjc.1977.258.
The role of immunotherapy in the management of patients with malignant melanoma.
Goodnight Jr J, Morton D
World J Surg. 1979; 3(3):309-20.
PMID: 382645
DOI: 10.1007/BF01556582.
[Immunfluorescence of human brain tumours (author's transl)].
Boker D
Acta Neurochir (Wien). 1978; 41(4):363-71.
PMID: 356525
DOI: 10.1007/BF01811349.
[The immunology of malignant melanoma (author's transl)].
Schieferstein G
Klin Wochenschr. 1978; 53(16):241-53.
PMID: 355711
[Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].
Fritz J, Grond K
Arch Dermatol Res (1975). 1977; 258(2):121-6.
PMID: 326202
DOI: 10.1007/BF00561616.
